Viagra experienced no impact on saquinavir pharmacokinetics. A more powerful CYP3A4 inhibitor such as ketoconazole or itraconazole may very well be anticipated to have larger impact than that seen with saquinavir. Population pharmacokinetic information from clients in medical trials also indicated a discount in sildenafil clearance when it was co-a